$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000144530513002604 Filed on October 31, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q3
Revenue	$33.56M	$23.26M	$8.486M
YoY Change	221.19%	174.09%	114.51%
Cost Of Revenue	$18.38M	$14.79M	$9.287M
YoY Change	89.99%	59.27%	176.65%
Gross Profit	$15.19M	$8.468M	-$801.0K
YoY Change	1852.19%	-1157.18%	-233.72%
Gross Profit Margin	45.25%	36.41%	-9.44%
Selling, General & Admin	$20.20M	$15.32M	$11.38M
YoY Change	50.75%	34.65%	128.84%
% of Gross Profit	133.0%	180.92%
Research & Development	$4.800M	$5.962M	$3.527M
YoY Change	50.0%	69.04%	-19.11%
% of Gross Profit	31.6%	70.41%
Depreciation & Amortization	$1.700M	$800.0K	$900.0K
YoY Change	17.24%	-11.11%	125.0%
% of Gross Profit	11.19%	9.45%
Operating Expenses	$43.38M	$36.07M	$24.19M
YoY Change	65.09%	49.11%	90.65%
Operating Profit	-$28.20M	-$12.81M	-$15.71M
YoY Change	10.57%	-18.41%	79.85%
Interest Expense	-$1.900M	$1.892M	$456.0K
YoY Change	533.33%	314.91%	-49.89%
% of Operating Profit
Other Income/Expense, Net	-$300.0K	-$1.970M	-$39.00K
YoY Change	50.0%	4951.28%	-94.97%
Pretax Income	-$12.00M	-$14.78M	-$15.75M
YoY Change	-26.38%	-6.1%	65.74%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$11.96M	-$14.78M	-$15.75M
YoY Change	-26.86%	-6.1%	65.6%
Net Earnings / Revenue	-35.62%	-63.56%	-185.54%
Basic Earnings Per Share	-$0.36	-$0.44	-$0.49
Diluted Earnings Per Share	-$0.36	-$0.44	-$0.49
COMMON SHARES
Basic Shares Outstanding	33.54M shares	33.36M shares	32.44M shares
Diluted Shares Outstanding		33.36M shares	32.44M shares

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$72.20M	$81.80M	$66.90M
YoY Change	75.67%	22.27%	80.32%
Cash & Equivalents	$12.52M	$3.383M	$8.709M
Short-Term Investments	$59.60M	$78.50M	$58.20M
Other Short-Term Assets	$4.400M	$4.500M	$3.800M
YoY Change	29.41%	18.42%	18.75%
Inventory	$15.56M	$15.61M	$11.91M
Prepaid Expenses
Receivables	$14.59M	$9.771M	$2.459M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$106.8M	$111.7M	$85.13M
YoY Change	75.23%	31.2%	96.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$48.18M	$45.94M	$35.32M
YoY Change	23.18%	30.08%	36.9%
Goodwill	$10.33M	$9.539M	$8.109M
YoY Change	24.48%	17.63%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.402M	$3.557M	$548.0K
YoY Change	565.75%	549.09%	-54.33%
Total Long-Term Assets	$63.07M	$60.71M	$47.70M
YoY Change	23.35%	27.28%	39.43%
TOTAL ASSETS
Total Short-Term Assets	$106.8M	$111.7M	$85.13M
Total Long-Term Assets	$63.07M	$60.71M	$47.70M
Total Assets	$169.8M	$172.4M	$132.8M
YoY Change	51.55%	29.79%	71.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.069M	$1.559M	$4.789M
YoY Change	19.46%	-67.45%	11.37%
Accrued Expenses	$17.89M	$15.57M	$13.04M
YoY Change	82.65%	19.46%	160.72%
Deferred Revenue
YoY Change
Short-Term Debt	$99.00M	$97.90M	$0.00
YoY Change
Long-Term Debt Due	$120.0M	$900.0K	$800.0K
YoY Change		12.5%	-87.1%
Total Short-Term Liabilities	$121.9M	$117.0M	$19.83M
YoY Change	761.42%	489.93%	11.21%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$24.93M
YoY Change	-100.0%	-100.0%	11.29%
Other Long-Term Liabilities	$3.190M	$2.911M	$2.399M
YoY Change	40.22%	21.34%	-89.79%
Total Long-Term Liabilities	$3.190M	$2.911M	$27.33M
YoY Change	-88.39%	-89.35%	-40.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$121.9M	$117.0M	$19.83M
Total Long-Term Liabilities	$3.190M	$2.911M	$27.33M
Total Liabilities	$128.6M	$123.3M	$52.38M
YoY Change	178.3%	135.35%	-17.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$296.4M	-$284.5M	-$216.2M
YoY Change	27.49%	31.59%
Common Stock	$34.00K	$34.00K	$32.00K
YoY Change	3.03%	6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$2.000K	$2.000K
YoY Change	-100.0%	0.0%
Treasury Stock Shares	0.000 shares	1.065K shares	1.065K shares
Shareholders Equity	$41.25M	$49.12M	$80.45M
YoY Change
Total Liabilities & Shareholders Equity	$169.8M	$172.4M	$132.8M
YoY Change	51.55%	29.79%	71.17%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	-$11.96M	-$14.78M	-$15.75M
YoY Change	-26.86%	-6.1%	65.6%
Depreciation, Depletion And Amortization	$1.700M	$800.0K	$900.0K
YoY Change	17.24%	-11.11%	125.0%
Cash From Operating Activities	-$6.900M	-$9.840M	-$11.18M
YoY Change	-67.42%	-11.99%	31.68%
INVESTING ACTIVITIES
Capital Expenditures	-$2.800M	-$4.700M	-$6.260M
YoY Change	-40.8%	-24.92%	281.71%
Acquisitions
YoY Change
Other Investing Activities	$18.02M	$8.310M	$4.450M
YoY Change	-33.48%	86.74%	-589.01%
Cash From Investing Activities	$15.22M	$3.610M	-$1.810M
YoY Change	-31.93%	-299.45%	-29.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	820.0K	980.0K	250.0K
YoY Change	241.67%	292.0%	2400.0%
NET CHANGE
Cash From Operating Activities	-6.900M	-9.840M	-11.18M
Cash From Investing Activities	15.22M	3.610M	-1.810M
Cash From Financing Activities	820.0K	980.0K	250.0K
Net Change In Cash	9.140M	-5.250M	-12.74M
YoY Change	543.66%	-58.79%	15.29%
FREE CASH FLOW
Cash From Operating Activities	-$6.900M	-$9.840M	-$11.18M
Capital Expenditures	-$2.800M	-$4.700M	-$6.260M
Free Cash Flow	-$4.100M	-$5.140M	-$4.920M
YoY Change	-75.08%	4.47%	-28.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	USD
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1559000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2569000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4352000	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9771000	USD
CY2013Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15573000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9792000	USD
CY2013Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11389000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11603000	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	17000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	27000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	298317000	USD
CY2013Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	333542000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	23956000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8227000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8227000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3220000	USD
CY2012Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1469000	USD
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3777000	USD
CY2013Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2924000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	571000	USD
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	USD
CY2012Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	USD
CY2012Q4	us-gaap	Assets Assets	112054000	USD
CY2013Q3	us-gaap	Assets Assets	172395000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	60922000	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	111685000	USD
CY2013Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	78447000	USD
CY2012Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	30897000	USD
CY2013Q3	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	14000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	1000	USD
CY2013Q3	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	31000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	28000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10126000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3383000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46168000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8709000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33514248	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32624049	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33513183	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32622984	shares
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	33000	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	34000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-35886000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15779000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-51963000	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14781000	USD
CY2012Q4	us-gaap	Convertible Debt ConvertibleDebt	0	USD
CY2013Q3	us-gaap	Convertible Debt ConvertibleDebt	120000000	USD
CY2012Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2013Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	97927000	USD
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	14791000	USD
CY2012Q3	us-gaap	Cost Of Revenue CostOfRevenue	9287000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	22467000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	36396000	USD
CY2013Q3	us-gaap	Depreciation Depreciation	800000	USD
CY2012Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2309000	USD
CY2013Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	22073000	USD
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	972000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	972000	USD
CY2013Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2991000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3720000	USD
CY2012Q3	us-gaap	Depreciation Depreciation	900000	USD
	us-gaap	Depreciation Depreciation	2500000	USD
	us-gaap	Depreciation Depreciation	2700000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4047000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4202000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.57
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.57
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.57
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	513000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	81000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	322000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	754000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1670000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3208000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-31000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2013Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2012Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3398000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1062000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	8297000	USD
CY2013Q3	us-gaap	Goodwill Goodwill	9539000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-52395000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-35935000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14784000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15745000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-442000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6421000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6849000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5419000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	346000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-15961000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-729000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10661000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3529000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-83000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	735000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	161000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	638000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	492000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	452000	USD
CY2012Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	500000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1400000	USD
CY2013Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	300000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	900000	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	456000	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	1892000	USD
	us-gaap	Interest Expense InterestExpense	5325000	USD
	us-gaap	Interest Expense InterestExpense	1464000	USD
	us-gaap	Interest Paid InterestPaid	3157000	USD
	us-gaap	Interest Paid InterestPaid	3290000	USD
CY2013Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4793000	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2017000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	218000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	12077000	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	15606000	USD
CY2013Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3859000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4081000	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5979000	USD
CY2013Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6954000	USD
CY2013Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	62000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	207000	USD
CY2012Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	87000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	46199000	USD
CY2013Q3	us-gaap	Liabilities Liabilities	123277000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112054000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	172395000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	116972000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14156000	USD
CY2013Q3	us-gaap	Long Term Debt LongTermDebt	97927000	USD
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	25191000	USD
CY2013Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25191000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-6743000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-37459000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	88352000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	63373000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-51881000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-58159000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-36936000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-48951000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-14784000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-51953000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-35935000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-15745000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2466000	USD
CY2012Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-39000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8925000	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1970000	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	24192000	USD
	us-gaap	Operating Expenses OperatingExpenses	62103000	USD
	us-gaap	Operating Expenses OperatingExpenses	95456000	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	36073000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-43470000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12814000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-33469000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-15706000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	34774000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5072000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5130000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4978000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4765000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	13734000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1095000	USD
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3557000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	511000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-10000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	49000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-10000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-34000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-34000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-10000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	49000	USD
CY2013Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2911000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2275000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-30000	USD
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-111000	USD
CY2012Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-48000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7191000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1365000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9368000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13525000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	54156000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	102114000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1920000	USD
CY2013Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2486000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	120000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62855000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	27500000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	54564000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	25950000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	633000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3043000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	50719000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57333000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45944000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39116000	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5962000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16724000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	26250000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	27500000	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3527000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6693000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1523000	USD
CY2013Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1975000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-232520000	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-284473000	USD
CY2012Q3	us-gaap	Revenues Revenues	8486000	USD
CY2013Q3	us-gaap	Revenues Revenues	23259000	USD
	us-gaap	Revenues Revenues	28634000	USD
	us-gaap	Revenues Revenues	51986000	USD
CY2012Q3	us-gaap	Royalty Expense RoyaltyExpense	-378000	USD
CY2013Q3	us-gaap	Royalty Expense RoyaltyExpense	132000	USD
	us-gaap	Royalty Expense RoyaltyExpense	47000	USD
	us-gaap	Royalty Expense RoyaltyExpense	379000	USD
CY2013Q3	us-gaap	Royalty Revenue RoyaltyRevenue	608000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1737000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	2082000	USD
CY2012Q3	us-gaap	Royalty Revenue RoyaltyRevenue	452000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	49520000	USD
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	22408000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	9978000	USD
CY2012Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4550000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32943000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42336000	USD
CY2012Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11378000	USD
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15320000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3220000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8227000	USD
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5204537	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	257652	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	4946885	shares
CY2012Q4	us-gaap	Short Term Investments ShortTermInvestments	30924000	USD
CY2013Q3	us-gaap	Short Term Investments ShortTermInvestments	78464000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3043000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	65855000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	49118000	USD
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1065	shares
CY2013Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	1065	shares
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2000	USD
CY2013Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2000	USD
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2012Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29586000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33360000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33051000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32436000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33359576	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29585716	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33050721	shares
CY2012Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	32436207	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29586000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33051000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33360000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32436000	shares
CY2013Q3	pcrx	Additional Sharebased Compensation Exepnse AdditionalSharebasedCompensationExepnse	200000	USD
	pcrx	Additional Sharebased Compensation Exepnse AdditionalSharebasedCompensationExepnse	200000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	337000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	-178000	USD
	pcrx	Class Of Warrant Or Right Value Of Warrant Issued With Debt ClassOfWarrantOrRightValueOfWarrantIssuedWithDebt	1354000	USD
	pcrx	Class Of Warrant Or Right Value Of Warrant Issued With Debt ClassOfWarrantOrRightValueOfWarrantIssuedWithDebt	0	USD
CY2013Q3	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	243000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	729000	USD
CY2012Q3	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3484000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	16574000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
	pcrx	Equity Premium Convertible Debt EquityPremiumConvertibleDebt	0	USD
	pcrx	Equity Premium Convertible Debt EquityPremiumConvertibleDebt	24936000	USD
CY2013Q3	pcrx	Goodwill Recorded For Earn Out Payments GoodwillRecordedForEarnOutPayments	1600000	USD
	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	1038000	USD
	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	336000	USD
CY2012Q4	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	26871000	USD
CY2013Q3	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	99271000	USD
CY2012Q4	pcrx	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	27500000	USD
CY2013Q3	pcrx	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	0	USD
	pcrx	Minimum Period For Which Available Cash And Cash Equivalents Short Term Investments And Revenue Will Be Sufficient To Meet Expenses MinimumPeriodForWhichAvailableCashAndCashEquivalentsShortTermInvestmentsAndRevenueWillBeSufficientToMeetExpenses	P12M
CY2012	pcrx	Number Of Major Customers NumberOfMajorCustomers	4	customer
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	10151000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	1241000	USD
CY2013Q3	pcrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	3679000	shares
	pcrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	1405000	shares
CY2012Q3	pcrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	1601000	shares
	pcrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	2823000	shares
CY2013Q1	pcrx	Proceeds From Sale Of Unused Net Operating Losses ProceedsFromSaleOfUnusedNetOperatingLosses	400000	USD
CY2013Q3	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	1344000	USD
CY2012Q4	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	1680000	USD
CY2012Q4	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	823000	USD
CY2013Q3	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	941000	USD
CY2012Q4	pcrx	Royalty Interest Obligation Noncurrent RoyaltyInterestObligationNoncurrent	857000	USD
CY2013Q3	pcrx	Royalty Interest Obligation Noncurrent RoyaltyInterestObligationNoncurrent	403000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33539162	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.

Files In Submission

Name	View Source	Status
0001445305-13-002604-index-headers.html	Edgar Link	pending
0001445305-13-002604-index.html	Edgar Link	pending
0001445305-13-002604.txt	Edgar Link	pending
0001445305-13-002604-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
pcrx-20130930.xml	Edgar Link	completed
pcrx-20130930.xsd	Edgar Link	pending
pcrx-20130930_cal.xml	Edgar Link	unprocessable
pcrx-20130930_def.xml	Edgar Link	unprocessable
pcrx-20130930_lab.xml	Edgar Link	unprocessable
pcrx-20130930_pre.xml	Edgar Link	unprocessable
pcrx-9302013x10xq.htm	Edgar Link	pending
pcrx-9302013xex101.htm	Edgar Link	pending
pcrx-9302013xex102.htm	Edgar Link	pending
pcrx-9302013xex103.htm	Edgar Link	pending
pcrx-9302013xex311.htm	Edgar Link	pending
pcrx-9302013xex312.htm	Edgar Link	pending
pcrx-9302013xex321.htm	Edgar Link	pending
pcrx-9302013xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2013 Q4 Form 10-Q Financial Statement

#000144530513002604 Filed on October 31, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2013 Q4 Form 10-Q Financial Statement

#000144530513002604 Filed on October 31, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx